ORMP   $2.33  3.10% Market Closed After Close 2.2 -5.58%

Oramed Pharmaceuticals Inc
Total Cash 152.74M
totalCashPerShare 3.746
EBITDA -12.65M
Total Debt 486.00K
quickRatio 40.915
currentRatio 41.058
Total Revenue 0.00
debtToEquity 0.276
Revenue/Share 0.0
ROA -0.04723
ROE 0.12699
grossProfits
freeCashflow -2.04M
operatingCashflow -1.51M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -57.35M
forwardPE -29.375
floatShares 35.05M
sharesOutstanding 40.77M
sharesShort 298.47K
sharesShortPriorMonth 354.39K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.17%
Short Ratio help_outline 3.37%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 4.358
Price To Book help_outline 0.54
earningsQuarterlyGrowth
netIncomeToCommon 20.86M
trailingEps 0.51%
forwardEps -0.08%
enterpriseToEbitda 4.53
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.0 3Q 2024
institutionsCount 65
lastUpdated Nov. 6, 2024, 5:24 p.m.